Belali Tareg M
Faculty of Applied Medical Sciences, University of Bisha, Bisha, Saudi Arabia.
J Blood Med. 2025 Aug 6;16:349-358. doi: 10.2147/JBM.S523353. eCollection 2025.
Hypercoagulability is one of the most reported state among Pregnant women. During pregnancy, the concentrations of D-dimer increase in a trimester-dependent- manner. The presence of gestational diabetes (GD) and gestational hypertension (GH) lead to further elevation in D-dimer levels. Pregnant women are at an increased risk of developing Venous thromboembolism (VTE), which can be fatal for both the mother and fetus. Elevated D-dimer levels during pregnancy could result in misdiagnosing other thrombotic diseases, emphasizing the need for further confirmatory testing for VTE. It is crucial to observe the plasma D-dimer concentrations among pregnant women at maternity and children's hospitals as it plays a role in guiding the anticoagulant treatments and minimizing the incidence of VTE among pregnant women.
The main objective of the current study was to detect the changes in the plasma D-dimer concentrations in healthy and complicated pregnancies across different gestational trimesters among women at the Maternity and Children's Hospital, Bisha, Saudi Arabia.
A cross-sectional study was conducted from March 2022 to March 2023, involving the analysis of plasma samples collected from 230 pregnant and non-pregnant women. Three samples were collected from each subject in each trimester. D-dimer measurement was conducted using an ACL Elite Pro Automated analyzer.
The findings of this study show that D-dimer levels increased progressively throughout the pregnancy trimesters across all study groups. The increase was more noticeable among women with gestational diabetes (278.39 ± 29.808 ng/mL) and gestational hypertension (320.63 ± 12.157 ng/mL), suggesting that these complications influence D-dimer levels more significantly than healthy and multiple pregnancies. Notably, a positive correlation was found between age and D-dimer levels across all groups (p < 0.05), with the highest mean levels in the 41-48 age group.
D-dimer levels rise progressively throughout pregnancy and are significantly elevated in women with gestational diabetes and hypertension. These findings underscore the importance of interpreting D-dimer values in the context of gestational age and pregnancy complications. Additionally, maternal age influences D-dimer concentrations, emphasizing the need to interpret results within the context of age-related physiological changes during pregnancy.
高凝状态是孕妇中报告最多的状态之一。在孕期,D - 二聚体浓度以依赖孕期的方式增加。妊娠期糖尿病(GD)和妊娠期高血压(GH)的存在会导致D - 二聚体水平进一步升高。孕妇发生静脉血栓栓塞症(VTE)的风险增加,这对母亲和胎儿都可能是致命的。孕期D - 二聚体水平升高可能导致其他血栓性疾病的误诊,这凸显了对VTE进行进一步确诊检测的必要性。在妇幼医院观察孕妇血浆D - 二聚体浓度至关重要,因为它在指导抗凝治疗和降低孕妇VTE发生率方面发挥作用。
本研究的主要目的是检测沙特阿拉伯比沙妇幼医院不同孕周的健康孕妇和合并症孕妇血浆D - 二聚体浓度的变化。
2022年3月至2023年3月进行了一项横断面研究,对230名孕妇和非孕妇采集的血浆样本进行分析。每个受试者在每个孕期采集三个样本。使用ACL Elite Pro自动分析仪进行D - 二聚体检测。
本研究结果表明,所有研究组的D - 二聚体水平在整个孕期均逐渐升高。在妊娠期糖尿病患者(278.39 ± 29.808 ng/mL)和妊娠期高血压患者(320.63 ± 12.157 ng/mL)中升高更为明显,这表明这些并发症对D - 二聚体水平的影响比健康孕妇和多胎孕妇更为显著。值得注意的是,所有组中年龄与D - 二聚体水平之间均存在正相关(p < 0.05),41 - 48岁年龄组的平均水平最高。
D - 二聚体水平在整个孕期逐渐升高,在妊娠期糖尿病和高血压患者中显著升高。这些发现强调了在孕周和妊娠并发症背景下解读D - 二聚体值的重要性。此外,母亲年龄会影响D - 二聚体浓度,这凸显了在孕期与年龄相关的生理变化背景下解读结果的必要性。